ldentification of Autoantibody Biomarkers for Colon Cancer Screening using Protein Microarrays

J. Luna-Coronell, Khulan Sergelen, Roland Kulovics, Andrea Gsur, Friedrich Längle, Andreas Weinhäusel

Publikation: Beitrag in Buch oder TagungsbandBeitrag in Tagungsband mit PosterpräsentationBegutachtung


lntroduction and Objectives Cancer has become a serious health problem. Early diagnosis can improve survival, thus, there is great need and anticipation to identify novel biomarkers for cancer diagnostics at the earliest stage as possible. The aim of this project is to identify tumor autoantibodies (TAA) and to develop a test which enables early identification of colon cancer patients. Materials and Methods We have produced a protein-array from 16,000 human cDNA expression clones. On these 16k protein arrays we have performed a candidate marker screening for identifying autoantibody profiles suitable for distinction of 4 groups, namely carcinoma patients, patients with polyps (low risk and high risk groups) and healthy controls. Biomarker screening was performed with isolated lgG from serum samples trom a test-set of 134 samples derived trom 99 serum patients between the 4 defined groups. Biostatistical microarray data was performed. A literature review was also made to check the reported colon TAAs Results Class prediction between carcinoma vs. control samples gave a mean percent of cor(ect classification of 89% of the samples, and cross-validation receiver operating characteristic (ROC) area under the curve of 0.938. Correct class prediction classification between controls vs. low risk samples resulted in 89%; low risk vs. high risk samples in 86%; and high risk vs. carcinoma samples 68%. A literature review was also made from published TAAs, and the classifier proteins which were found in the 16k human cDNA expression clones were added to the resulting clone list. Conclusion Biostatistics results showed that the samples, could be differentiated between the defined groups. In the end, a total of 729 candidate markers were selected and will be used to generate targeted micro-arrays. Validation of these previous results will take place using a validation-set of serum samples from 100 individuals per group and tumor entity (n=400).
Titel5 th Life Science Meeting Innsbruck, ÖGMBT Jahrestagung 2013
PublikationsstatusVeröffentlicht - 2013
Veranstaltung5 th Life Science Meeting Innsbruck, ÖGMBT Jahrestagung 2013 -
Dauer: 24 Sept. 201327 Sept. 2013


Konferenz5 th Life Science Meeting Innsbruck, ÖGMBT Jahrestagung 2013

Research Field

  • Ehemaliges Research Field - Health and Bioresources


Untersuchen Sie die Forschungsthemen von „ldentification of Autoantibody Biomarkers for Colon Cancer Screening using Protein Microarrays“. Zusammen bilden sie einen einzigartigen Fingerprint.

Diese Publikation zitieren